Ranbaxy Laboratories | Evaluate

October 15, 2014

Shabbvie marks difference between great and exceptional deal quarter

Delayed Diovan generic emerges – Valcyte and Nexium next?

May 16, 2014

Novartis settles Gleevec as other patent fights continue

April 07, 2014

Daiichi’s ill-timed Indian foray ends in minority Sunbaxy stake

January 07, 2014

Biotech bull run leaves few big cap drug stocks down in 2013

October 22, 2013

Clock ticks for Ranbaxy as Novartis continues to reap Diovan revenues

October 01, 2013

Surging US drives strong drug stock performances at nine month stage

September 02, 2013

ESC – Daiichi joins the US-EU blood-thinning race with positive Lixiana data

July 03, 2013

Biotech continues to reward investors in first half

April 04, 2013

Biotech consolidates its dominance in the first quarter

September 28, 2012

Supreme Court could be next up in "pay for delay" saga

Load More